RNAZ - Transcode Therapeutics, Inc.
9.6
0.270 2.813%
Share volume: 11,008
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$9.33
0.27
0.03%
Summary score
38%
Profitability
35%
Dept financing
31%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-93.47%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
58.72%
Debt ratio change over timeo
0%
Current Ratio
2.18%
Quick Ratio
0%
Cash Position Ratio
1.63%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-92.2%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
47.35%
Debt ratio change over timeo
0%
Current Ratio
3.4%
Quick Ratio
0%
Cash Position Ratio
2.78%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-92.8%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
72.72%
Debt ratio change over time
0%
Current Ratio
1.6%
Quick Ratio
0%
Cash Position Ratio
0.96%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAZ | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 13.23% | 9.84% | 26.17% |
| Return on assets | -93.47% | 4.59% | 3.2% | 1.81% |
| Return on sales | 0% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 0% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 58.72% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | 0% | -16.59% | -73.52% | 21.11% |
| Dept financing | 16% | 22% | 16% | 50% |
| Current Ratio | 3.4% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.78% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 41% | 47% | 33% |
| Short-term ratios | RNAZ | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -92.2% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 47.35% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 37% | 20% | 15% | 25% |
| Current Ratio | 3.4% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.78% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 36% | 33% | 21% |